Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Scholar Rock Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11322
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the application in the treatment of fibrosis, diseases of musculoskeletal systems, and autoimmune diseases. Scholar Rock’s lead product candidate include SRK-015, a selective inhibitor which activates latent myostatin in skeletal muscle used for the treatment of spinal muscular atrophy (SMA). The company is creating a pipeline of novel product candidates for a wide range of serious diseases such as neuromuscular disorders, cancer, fibrosis, and anemia. It collaborates with various biotechnology companies for the development of its pipeline products. Scholar Rock is headquartered in Cambridge, Massachusetts, the US.

Scholar Rock Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Scholar Rock Raises USD47 Million in Series C Financing 10
Scholar Rock Raises USD36 Million in Series B Financing 12
Scholar Rock Raises USD20 Million in Series A Venture Financing 14
Partnerships 16
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 16
Licensing Agreements 17
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 17
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 18
Scholar Rock Inc – Key Competitors 19
Scholar Rock Inc – Key Employees 20
Scholar Rock Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Aug 08, 2018: Scholar Rock reports second quarter 2018 financial results and updates on business progress 22
Corporate Communications 24
Apr 09, 2018: Scholar Rock Appoints Rhonda Chicko as Chief Financial Officer 24
Jul 06, 2017: Scholar Rock Appoints David L. Hallal as Chairman of Board of Directors 25
May 23, 2017: Scholar Rock Announces Drug Development Leaders, Michael Gilman and Shelia Violette, to Join Scientific Advisory Board 26
Product News 28
01/23/2018: Scholar Rock and Collaborators at Harvard Medical School and Northeastern University Elucidate Molecular Basis of Myostatin Activation – a Key Physiological Process in Muscle Health 28
Clinical Trials 29
Jul 10, 2017: Scholar Rock and the Miami Project to Cure Paralysis Present Preclinical Data Demonstrating Therapeutic Potential of SRK-015 in Spinal Cord Injury at 35th Annual National Neurotrauma Symposium 29
Jun 28, 2017: Scholar Rock to Develop SRK-015 to Improve Muscle Function in Patients with Spinal Muscular Atrophy 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Scholar Rock Inc, Pharmaceuticals & Healthcare, Key Facts 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scholar Rock Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scholar Rock Raises USD47 Million in Series C Financing 10
Scholar Rock Raises USD36 Million in Series B Financing 12
Scholar Rock Raises USD20 Million in Series A Venture Financing 14
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 16
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 17
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 18
Scholar Rock Inc, Key Competitors 19
Scholar Rock Inc, Key Employees 20

List of Figures
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laissez-Faire Catering Pty Ltd
    Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, designs, develops and manufactures dermal regeneration solutions for various medical applications. The company offers NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic, biodegradable and biocompatible device that facilitates the growt …
  • Manitoba Hydro-Electric Board:企業の発電所・SWOT分析2018
    Manitoba Hydro-Electric Board - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • MBNA Ltd:企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • TreeHouse Foods, Inc.:企業のM&A・事業提携・投資動向
    TreeHouse Foods, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TreeHouse Foods, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aldevron LLC (Aldevron) is a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services. The company develops and manufactures plasmid deoxyribonucleic acid (Plasmid DNA), proteins and antibodies for research, preclinical and clinical applications serv …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • SQI Diagnostics Inc (SQD):企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. It provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. I …
  • Papyrus Australia Limited (PPY):企業の財務・戦略的SWOT分析
    Papyrus Australia Limited (PPY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Forrester Research Inc (FORR):企業の財務・戦略的SWOT分析
    Summary Forrester Research Inc (Forrester) is a market research company that offers research and advisory services. The company offers services such as custom consulting, proprietary research, consumer and business data, worldwide events and peer executive programs. Forrester provides research for p …
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • New England Biolabs Inc-製薬・医療分野:企業M&A・提携分析
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • Riverbed Technology Inc:企業の戦略的SWOT分析
    Riverbed Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Alberici Corp:企業の戦略的SWOT分析
    Alberici Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Kosmos Energy Ltd (KOS):石油・ガス:M&Aディール及び事業提携情報
    Summary Kosmos Energy Ltd. (Kosmos) is an independent oil and gas exploration and production company. Its primary areas of operation are frontier and emerging areas along the Atlantic Margin. The company’s asset portfolio includes existing production and development projects offshore Ghana, discover …
  • Biosearch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biosearch Technologies Inc (Biosearch), a subsidiary of LGC Ltd is a biotechnology company that designs and manufactures regents. The company develops, and manufactures custom oligonucleotide-based tools. Its products include valupanel reagents, fluorogenic probes and primers, stellaries RNA …
  • YO Sushi UK Ltd:企業の戦略・SWOT・財務情報
    YO Sushi UK Ltd - Strategy, SWOT and Corporate Finance Report Summary YO Sushi UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fluent Inc (FLNT):企業の財務・戦略的SWOT分析
    Fluent Inc (FLNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Kolltan Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Kolltan Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kolltan Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆